Thursday, January 05, 2017 3:35:07 PM
Healthcare IT VAR business has showed growth($6.3Mil backlog vs $3.7Mil)
and they are guiding for stronger GEHC equipment deliveries in Q4 and this likely means further IT growth.
At .12 VASO has a market cap of $19.5 Mil which is about 1 quarter of sales. Thru 3 quarters in 2016 VASO has sales of $53.3Mil and net income of about 500K. They will likely end the year with around $75Mil in sales vs $57Mil in 2015.
Q4 net income has been huge in recent years with $2.7Mil in 2015 and $2.5Mil in 2014. If this is repeated again in 2016 the stock is way undervalued.
Also, going in to Q4 the company had $5.7Mil in cash.
My thoughts are this stock can very easily be back in the .20s on a good report come March.
Longer term they should continue to grow which makes for a great long term hold IMO
Recent VASO News
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 03/06/2024 09:58:30 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/11/2023 07:10:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:00:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM